Nanoformulated Zoledronic Acid Boosts the Vδ2 T Cell Immunotherapeutic Potential in Colorectal Cancer

Aminobisphosphonates, such as zoledronic acid (ZA), have shown potential in the treatment of different malignancies, including colorectal carcinoma (CRC). Yet, their clinical exploitation is limited by their high bone affinity and modest bioavailability. Here, ZA is encapsulated into the aqueous cor...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Mascolo, Daniele, Varesano, Serena, Benelli, Roberto, Mollica, Hilaria, Salis, Annalisa, Zocchi, Maria Raffaella, Decuzzi, Paolo, Poggi, Alessandro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017311/
https://www.ncbi.nlm.nih.gov/pubmed/31906080
http://dx.doi.org/10.3390/cancers12010104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7017311/
https://www.ncbi.nlm.nih.gov/pubmed/31906080
http://dx.doi.org/10.3390/cancers12010104

Ejemplares similares